We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$118M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$117M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$108M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$66M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$65.9M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$76.5M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$63.3M
3
SYY icon
Sysco
SYY
+$59.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$53.9M
5
CAH icon
Cardinal Health
CAH
+$40.6M

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
3026
CALL
Comcast
CMCSA
$88.8B
$89K ﹤0.01%
41,000
-3,000
-7% -$100K
VIVS
3027
VivoSim Labs
VIVS
$1.28M
$89K ﹤0.01%
109
+11
+11% +$8.73K
FGP
3028
DELISTED
Ferrellgas Partners, L.P.
FGP
$88K ﹤0.01%
13,038
-2,372
-15% -$19K
GSV
3029
DELISTED
Gold Standard Ventures Corp.
GSV
$87K ﹤0.01%
40,994
+23,905
+140% +$54.8K
CLNE icon
3030
Clean Energy Fuels
CLNE
$346M
$86K ﹤0.01%
30,043
+9,689
+48% +$36.6K
HL icon
3031
Hecla Mining
HL
$11.7B
$86K ﹤0.01%
16,378
+5,135
+46% +$30.1K
KNDI
3032
Kandi Technologies Group
KNDI
$63.8M
$85K ﹤0.01%
17,400
+4,000
+30% +$19.8K
SAND
3033
DELISTED
Sandstorm Gold
SAND
$85K ﹤0.01%
21,700
-33,000
-60% -$138K
FGB
3034
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
$84K ﹤0.01%
11,907
– –
HPE icon
3035
CALL
Hewlett Packard
HPE
$73.3B
$84K ﹤0.01%
103,061
-10,496
-9% -$140K
AVP
3036
DELISTED
Avon Products, Inc.
AVP
$84K ﹤0.01%
16,585
-361
-2% -$2.1K
FOMX
3037
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$82K ﹤0.01%
35,500
-1,200
-3% -$11.3K
RAS
3038
DELISTED
RAIT Financial Trust
RAS
$81K ﹤0.01%
23,999
+967
+4% +$2.98K
GSAT icon
3039
Globalstar
GSAT
$10.9B
$80K ﹤0.01%
3,367
-333
-9% -$5.22K
T icon
3040
CALL
AT&T
T
$164B
$79K ﹤0.01%
+68,716
New +$2.03M
USB icon
3041
CALL
US Bancorp
USB
$99.7B
$76K ﹤0.01%
46,800
+31,800
+212% +$1.51M
AERI
3042
CALL
DELISTED
Aerie Pharmaceuticals
AERI
$74K ﹤0.01%
23,800
– –
INO icon
3043
Inovio Pharmaceuticals
INO
$72.7M
$73K ﹤0.01%
876
-183
-17% -$16.5K
WFC icon
3044
CALL
Wells Fargo
WFC
$264B
$72K ﹤0.01%
+13,300
New +$669K
DIS icon
3045
CALL
Walt Disney
DIS
$178B
$71K ﹤0.01%
+14,900
New +$1.45M
MRK icon
3046
CALL
Merck
MRK
$322B
$71K ﹤0.01%
106,791
+88,870
+496% +$5.2M
ARCO icon
3047
Arcos Dorados Holdings
ARCO
$1.69B
$70K ﹤0.01%
13,362
+1,028
+8% +$5.86K
TTI icon
3048
TETRA Technologies
TTI
$1.27B
$70K ﹤0.01%
13,852
-13,310
-49% -$72K
KERX
3049
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$70K ﹤0.01%
11,905
-2,537
-18% -$13.9K
VUZI icon
3050
Vuzix
VUZI
$223M
$69K ﹤0.01%
+10,100
New +$75.3K
120 121
122
123 124

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.